Definium Therapeutics, Inc. (DFTX)
39.27
+0.46
(+1.19%)
USD |
NASDAQ |
Sep 21, 16:00
39.27
0.00 (0.00%)
After-Hours: 20:00
Definium Therapeutics Total Return Price : 39.27 for Sept. 21, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| September 18, 2026 | 38.81 |
| September 17, 2026 | 38.68 |
| September 16, 2026 | 37.85 |
| September 15, 2026 | 36.82 |
| September 14, 2026 | 40.25 |
| September 11, 2026 | 38.89 |
| September 10, 2026 | 37.73 |
| September 09, 2026 | 37.99 |
| September 08, 2026 | 38.23 |
| September 04, 2026 | 38.09 |
| September 03, 2026 | 38.00 |
| September 02, 2026 | 38.90 |
| September 01, 2026 | 38.50 |
| August 31, 2026 | 39.72 |
| August 28, 2026 | 40.98 |
| August 27, 2026 | 43.82 |
| August 26, 2026 | 43.77 |
| August 25, 2026 | 44.81 |
| August 24, 2026 | 43.27 |
| August 21, 2026 | 44.91 |
| August 20, 2026 | 45.40 |
| August 19, 2026 | 45.82 |
| August 18, 2026 | 46.18 |
| August 17, 2026 | 45.26 |
| August 14, 2026 | 42.63 |
| Date | Value |
|---|---|
| August 13, 2026 | 43.90 |
| August 12, 2026 | 42.79 |
| August 11, 2026 | 40.91 |
| August 10, 2026 | 45.15 |
| August 07, 2026 | 46.14 |
| August 06, 2026 | 46.14 |
| August 05, 2026 | 44.39 |
| August 04, 2026 | 42.32 |
| August 03, 2026 | 41.79 |
| July 31, 2026 | 43.52 |
| July 30, 2026 | 44.49 |
| July 29, 2026 | 42.16 |
| July 28, 2026 | 41.96 |
| July 27, 2026 | 42.65 |
| July 24, 2026 | 43.17 |
| July 23, 2026 | 42.93 |
| July 22, 2026 | 43.67 |
| July 21, 2026 | 45.08 |
| July 20, 2026 | 42.80 |
| July 17, 2026 | 44.29 |
| July 16, 2026 | 44.10 |
| July 15, 2026 | 45.66 |
| July 14, 2026 | 45.98 |
| July 13, 2026 | 43.65 |
| July 10, 2026 | 47.07 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| Enliven Therapeutics, Inc. | 48.86 |
| Cocrystal Pharma, Inc. | 1.205 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| GB Sciences, Inc. | 0.0002 |
| Arvinas, Inc. | 8.295 |